The effects of central administration of neuropeptide Y on behavior, neurotransmitter, and immune functions in the olfactory bulbectomized rat model of depression

Brain, Behavior, and Immunity

Volumn 10, Issue 1, 1996, Pages 1-16

  Song, Cai ^a   Earley, Bernadette ^b   Leonard, B E ^b  

^a CARLETON UNIVERSITY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; NEUROPEPTIDE Y; NEUROTRANSMITTER; NORADRENALIN;

AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; DEFECATION; DEPRESSION; GROOMING; HYPOTHALAMUS; LEUKOCYTE DIFFERENTIAL COUNT; LYMPHOCYTE PROLIFERATION; MALE; MAZE TEST; MOBILIZATION; NEUROCHEMISTRY; NEUROTRANSMISSION; NONHUMAN; OLFACTORY BULBECTOMY; PRIORITY JOURNAL; RAT; REARING;

EID: 0029893516     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1006/brbi.1996.0001     Document Type: Article

References (72)

1. Arango, V., Ernsberger, P., Underwood, M. D., & Mann, J. J. (1990). Alpha2-adrenergic binding is not altered in suicide. Soc. Neurosci. Abstr. 16, 59.9.
2. Baldessarini, R. J. (1975). The basis for amine hypotheses in affective disorder: a critical evaluation. Arch. Gen. Psychiat. 32, 1087-1093.
3. Beskow, J., Gottfries, C. G., Roos, B. E., & Winblad, B. (1976). Determination of monoamine and metabolites in the human brain: postmortem studies in a group of suicides and in a control group. Arch. Psychiat. Scand. 53, 7-20.
4. Britton, K. T., Koob, G. F., & Rivier, J. (1982). CRF enhanced behavioural effects of novelty. Life Sci. 31, 363-367.
5. Biondi, M., & Kotzalidis, G. D. (1990). Human psychoneuroimmunology today. J. Clin. Lab. Anal. 4, 22-38.
6. Boranic, M., Pericic, D., Poljak-Blazi, M., Manev, H., Sverko, V., Gabrilovac, J., Radacic, M., & Miljenovic, G. (1990). Immune response of stressed rats treated with grugs affecting serotoninergic and adrenergic transmission. Biomed. Pharmacother. 44, 381-387.
7. Cairncross, K. D., Cox, B., Forster, C., & Wren, A. E. (1979). Olfactory projection system, drugs and behaviour: a review. Psychoneuroendocrinology 4, 253-272.
8. Calza, L., Giardino, L., Zanni, M., Velardo, A., Parchi, P., & Marrama, P. (1990). Daily changes of neuropeptide Y-like immunoreactivity in the suprachiasmatic nucleus of the rat. Regul. Pept. 27, 127-137.
9. Cheetham, S. C., Compton, M. R., Katona, C. L. E., & Horton, R. W. (1990). Brain 5-HT1 binding sites in depressed suicides. Psychopharmacology 102, 544-548.
10. Chronwall, B. M., DiMaggio, D. A., Massari, V. J., Pickel, V. M., Ruggiero, D. A., & O'Donohue, T. L. (1985). The anatomy of neuropeptide Y containing neurons in rat brain. Neuroscience 15, 1159-1181.
11. Coleman, R. M., Lombard, M. F., Sicard, R. E., & Rencricea, N. J. (1989). Fundamental immunology, E. G. Jaffe (Ed.), pp. 60-65. Brown: Dubuque, Iowa.
12. Corr, L., Burnstock, G., & Poole-Wilson, P. (1993). Effects of age and hyperlipidemia on rabbit coronary responses to neuropeptide Y and the interaction with norepinephrine. Peptides 14, 359-364.
13. Crow, T. J., Cross, A. J., Cooper, S. J., Deakin, J. F. W., Ferrier, I. N., Johnson, J. A., Joseph, M. H., Owen, F., Poulter, M., Lofthouse, R., Corsellis, J. A. N., Chambers, D. R., Blessed, G., Perry, E. K., Perry, R. H., & Tomlinson, B. E. (1984). Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression and suicides. Neuropharmacology 23, 1561-1569.
14. DeQuidt, M. E., & Emson, P. C. (1986). Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system: I. Radioimmunoassay and chromatographic characterisation. Neuroscience 18, 527-543.
15. Dureus, P., Louis, D., Grant, A. V., Bilfinger, T. V., & Stefano, G. B. (1993). Neuropeptide-Y inhibits human and invertebrate immunocyte chemotaxis, chemokinesis, and spontaneous activation. Cell. Mol. Neurobiol. 13, 541-546.
16. Felten, S. Y., & Olschowka, J. (1987). Noradrenergic sympathetic innervation of the spleen. II. Tyrosine hydroxylase (TH) positive nerve terminals form synaptic-like contacts on lymphocytes in the splenic white pulp. J. Neurosci. Res. 18, 23-26.
17. Fillion, L., Belles-Isles, M., Lemyre, L., & Roy, R. (1994). Reliability of lymphocyte proliferation assays. Stress Med. 10, 43-48.
18. Fuxe, K., Agnati, L. F., Harfstrand, A., Zoli, M., von Euler, G., Grimaldi, R., Merio-Pich, E. et al. (1990). On the role of neuropeptide Y in information handling in the central nervous system in normal and physiopathological states. Focus on volume transmission and neuropeptide Y/alpha 2 receptor interaction. Ann. N.Y. Acad. Sci. 579, 28-67.
19. Garcia, L., Perez-Castillo, A., Moreno, J., & Alemany, S. (1992). Beta-endorphin inhibits interleukin-2 release and expression of interleukin-2 receptors in concanavalin-A-stimulated splenic lymphocytes. Lymphokine Cytokine Res. 11, 339-345.
20. Glick, D., von Redlich, D., & Levine, S. (1964). Fluorimetric determination of corticosterone and cortisol in 0.02-0.05 milliliters of plasma or submilligram samples of adrenal tissue. Endocrinology 74, 653-655.
21. Gray, J. A., & Laljee, B. (1974). Sex differences in emotional behaviour in the rat: Correlation between the "open field" defeacation and avoidance behaviour. Anim. Behav. 22, 856-861.
22. Gue, M., Yoneda, H., Monnikes, H., Junien, J. L., & Tache, Y. (1992). Central neuropeptide Y and sigma ligand, JO 1784, reverse corticotropin-releasing factor-induced inhibition of gastric acid secretion in rats. Br. J. Pharmacol. 107, 642-647.
23. Han, B., Kelly, J. P., & O'Donnell, J. M. (1993). Effects of surgical olfactory bulbectomy or neurotoxin administration on behaviour and neuroendocrine responsiveness in rats. Ir. J. Med. Sci. 162, 386.
24. Heffner, T. G., Hartman, J. A., & Seiden, L. S. (1980). A rapid method for the regional dissection of the rat-brain. Pharmacol. Biochem. Behav. 13, 453-456.
25. Heilig, M., Wahlestedt, C., Ekman, R., & Widerlov, E. (1988). Antidepressant drugs increase the concentration of neuropeptide Y (NPY)-like immunoreactivity in the rats brain. Eur. J. Pharmacol. 147, 456-467.
26. Heilig, M., Vecsei, L., Wahlestedt, C., Alling, Ch., & Widerlov, E. (1990). Effects of centrally administered neuropeptide Y (NPY) and NPY 13-36 on the brain monoaminergic systems of the rat. J. Neural. Transm. 79, 193-208.
27. Heilig, M., Koob, G. F., Ekman, R., & Britton, K. T. (1994). Corticotropin-releasing factor and neuropeptide Y: role in emotional integration. Trends Neurosci. 17, 80-85.
28. Hosker, H. S. R., Kelly, C., & Corri, P. A. (1989). Assessment of phagocytic function using chemiluminescence. Blood Rev. 3, 88-93.
29. Inui, A., Okita, M., Inoue, T., Sakatani, N., Morioka, H., Shii, K., Yokono, K., Mizuno, N., & Baba, S. (1989). Characterization of peptide YY receptors in the brain. Endocrinology 124, 402-409.
30. Irwin, M., Hauger, R., & Brown, M. (1992). Central corticotropin-release hormone activates the sympathetic nervous system and reduces immune function. Endocrinology 131, 1047-1053.
31. Jancsar, S., & Leonard, B. E. (1984). Changes in neurotransmitter metabolism following olfactory bulbectomy in the rat. Prog. Neuropsychopharmac. Biol. Psychiat. 8, 263-269.
32. Junien, J. L., Gue, M., & Bueno, L. (1991). Neuropeptide Y and sigma ligand (JO 1784) act though a Gi protein to block the psychological stress and corticotropin-release factor-induced colonic motor activation in rats. Neuropharmacology 30, 119-124.
33. Kelly, J. P. (1991). The olfactory bulbectomized rat as a model of depression: Biochemical behavioural and pharmacological correlates. Ph. D. thesis, National University of Ireland, Dublin.
34. Lehmann, J. (1990). Neuropeptide Y: An overview. Drug Dev. Res. 19, 329-351.
35. Leonard, B. E., & Tuite, M. (1981). Anatomical physiological and behavioral aspects of olfactory bulbectomy in the rat. Int. Rev. Neurosci. 22, 251-286.
36. Leonard, B. E. (1984). The olfactory bulbectomized rat as a model of depression. Pol. J. Pharmacol. Pharm. 36, 561-569.
37. Lesniewska, B., Nowak, M., Miskowiak, B., Nussdorfer, G. G., & Malendowicz, L. K. (1990). Long-term effects of neuropeptide Y on the rat adrenal cortex. Neuropeptides 16, 9-13.
38. Little, K., Duncan, G., & Breese, G. R. (1990). Beta-adrenergic binding in suicide victims. Soc. Neurosci. Abstr. 16, 59.9.
39. Mann, J. J., Stanley, M., McBride, A., & McEwan, B. S. (1986). Increased serotonin-2 and adrenergic receptor binding in the frontal cortices of suicide victims. Arch. Gen. Psychiat. 43, 954-985.
40. 125I]Bolton-Hunter neuropeptide Y binding sites in the forebrain of various mammalian species. Brain Res. 419, 403-407.
41. Martel, J., Fournier, A., C., St-Pierre, S., Dumont, Y., Forest, M., & Quirion, R. (1990). Comparative structural requirements of brain neuropeptide Y binding sites and vas deferens neuropeptide Y receptors. Mol. Pharmacol. 38, 494-502.
42. McAdams, C., & Leonard, B. E. (1993). Neutrophil and monocyte phagocytosis in depressed patients. Prog. Neuropsychopharmac. Biol. Psychiat. 17, 971-984.
43. McKeith, I. G., Marshall, E. F., Ferner, I. N., Armstrong, M. M., Kennedy, W. N., Perry, R. H., Perry, E. K., & Eccleston, D. (1987). 5-HT receptor binding in post-mortem brain from patients with affective disorder. J. Affect. Disord. 13, 67-74.
44. Meretey, K., Antal, M., Rozsnyay, Z., Bohm, V., Elekes, E., & Genti, G. (1987). PHA and Con A-induced chemiluminescence of human blood mononuclear cells and granulocytes in luminol or lucigenin. Inflammation 11, 417-425.
45. Nair, M. P. N., Schwartz, S. A., Wu, K., & Kronfol, Z. (1993). Effect of neuropeptide Y on natural killer activity of normal human lymphocytes. Brain Behav. Immun. 7, 70-78.
46. Nair, N. P. V., & Sharma, M. (1989). Neurochemical and receptor theories of depression. Psychiatr. J. Univ. Ottawa 14, 328-341.
47. O'Connor, W. T., & Leonard, B. E. (1986). Effect of chronic administration of the 6-aza analogue of mianserin (ORG 3770) and its enantiomers on behaviour and noradrenaline metabolism of olfactory bulbectomized rats in the "open field" apparatus. Neuropharmacology 25, 267-270.
48. Ordway, G. A., Widdowson, P. S., Streator-Smith, K., & Halaris, A. E. (1990). Neurochemistry of the human locus coeruleus in suicide and depression. Soc. Neurosci. Abstr. 16, 59.8.
49. O'Neill, B., O'Connor, W. T., & Leonard, B. E. (1987). Depressed neutrophil phagocytosis in the rat following olfactory bulbectomy reversed by chronic desipramine treatment. Med. Sci. Res., 15, 267-268.
50. Pellow, S., Chopin, P., File, S., & Briley, M. (1985). Validation of open: Closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods 14, 149-167.
51. Roitt, I., (1980). For an overview of phagocytosis: Essential immunology, 4th ed., Chap. 7. Blackwell: Oxford, England.
52. Romano, T. A., Felten, S. Y., Felten, D. L., & Olschowka, J. A. (1991). Neuropeptide-Y innervation of the rat spleen-Another potential immunomodulatory neuropeptide. Brain Behav. Immun. 5, 116-131.
53. Rosier, A. M., Orban, G. A., & Vandesande, F. (1990). Regional distribution of binding sites for neuropeptide Y in cat and monkey visual cortex determined by in vitro receptor autoradiography. J. Comp. Neurol. 293, 486-498.
54. Sandi, C., Cambronero, J. C., Borrell, J., & Guaza, C. (1992). Effects of HPA hormone on adapted lymphocyte responsiveness to repeated stress. Brain Res. Bull. 28, 581-585.
55. Schildkraut, J. J. (1965). The catecholamine hypothesis of affective disorders: A review of supporting evidence. Am. J. Psychiat. 122, 509-522.
56. Seyfried, C. A., Adam, G., & Greve, G. (1986). An automated direct-injection HPLC-method for the electrochemical/fluorimetric quantitation of monoamines and related compounds optimized for the screening of large numbers of animals. Biomed. Chromatogr. 1, 78-88.
57. Smith, R. S. (1991). The macrophage theory of depression. Med. Hypotheses 35, 298-306.
58. Song, C., & Leonard, B. E. (1994a). The effects of chronic lithium chloride administration on some behaviour and immunological changes in the bilaterally olfactory bulbectomized rat. J. Psychopharmac 8, 40-47.
59. Song, C., & Leonard, B. E. (1994b). Serotonin reuptake inhibitors reverse the impairments in behavior, neurotransmitter and immune functions in the olfactory bulbectomized rat. Hum. Psychopharmacol. 9, 135-146.
60. Song, C., & Leonard, B. E. (1995). The effect of olfactory in the rat, alone or in combination with antidepressants and endogenous factor, on immune function. Hum. Psychopharmacol. 10, 7-18.
61. Song, C., & Leonard, B. E. (1996). Interleukin-2 induced changes in behavior, neurotransmitter and immune functions in the olfactory bulbectomized rat. NeuroImmunModulation, in press.
62. Song, C., Lascosta, S., Anisman, H., & Merali, Z. (1995). Interactions of stress and cytokines (IL-1β and IL-2) at the nucleus accumbens: An in vivo microdialysis study. Canadian College of Neuropsychopharmacology, 18th annual meeting. [Abstract 21].
63. van Riezen, H., & Leonard, B. E. (1990). Effects of psychotropic drugs on the behaviour and neurochemistry of olfactory bulbectomized rats. Pharmacol. Ther. 47, 21-34.
64. Wahlestedt, C., Ekman, R., & Widerlov, E. (1989). Neuropeptide Y (NPY) and the central nervous system: distribution effects and possible relationship to neurological and psychiatric disorders. Prog. Neuro-Psychopharmac. Biol. Psychiat. 13, 31-54.
65. Werner, H., Paegelow, I., Meyer-Rienecher, H., & Bienert, M. (1987). Interaction between lymphocyte and neurotransmitters. Ann. N.Y. Acad. Sci. 496, 312-315.
66. Wettstein, J. G., Earley, B., & Junien, J. L. (1995). Central nervous system pharmacology of neuropeptide Y. Pharmacol. Ther. 65, 397-414.
67. Widdowson, P. S., & Halaris, A. E. (1989). Increased levels of neuropeptide-Y immunoreactivity in rat brain limbic structures following antidepressant treatment. J. Neurochem. 52(Suppl.), S77. [Abstract]
68. Winddowson, P. S., Ordway, G. A., & Halaris, A. E. (1992). Reduced neuropeptide Y concentrations in suicide brain. J. Neurochem. 59, 73-80.8.
69. Widerlov, E., Wahlestedt, C., Hakanson, R., & Ekman, R. (1986). Altered brain neuropeptide function in psychiatric illness-with special emphasis on NPY and CRF in major depression. In Proc. C.I.N.P. 15th Congress, Clin. Neuropharmacol. 9, Suppl. 4, 572-574.
70. Widerlov, E., Heilig, M., Ekman, R., & Wahlestedt, C. (1988). Possible relationship between neuropeptide Y (NPY) and major depression: Evidence from human and animal studies. Nord. J. Psychiat. 42, 131-137.
71. Winer, B. J. (1971). Statistical principles in experimental design, 2nd ed., pp. 199-201. McGraw-Hill: New York.
72. 2 receptor changes in major depression. Biol. Psychiat. 27, 489-496.